Tempest Therapeutics (TPST) Projected to Post Quarterly Earnings on Wednesday

Chronological Source Flow
Back

AI Fusion Summary

Tempest Therapeutics (TPST) is slated to report Q4 2025 earnings on April 1, 2026, with analysts forecasting a loss of $0.62 per share. The company’s stock, trading around $1.75, has a market cap of $8.63 M and a negative P/E ratio.
#Tempest Therapeutics #Q4 earnings #stock price #market cap #negative P/E #biotech #earnings forecast
25/03 07:04 defenseworld.net
2 Πηγές

Tempest Therapeutics (TPST) Projected to Post Quarterly Earnings on Wednesday

Tempest TherapeuticsQ4 earningsstock pricemarket capnegative P/Ebiotech
25/03 09:08 defenseworld.net

ZyVersa Therapeutics (ZVSA) Projected to Post Quarterly Earnings on Wednesday

POLITICSCOMPANIESEARNINGS PREVIEWS
Comments
Loading...
0